Please use this identifier to cite or link to this item:
Title: Supreme™ laryngeal mask airway use in general Anesthesia for category 2 and 3 Cesarean delivery: A prospective cohort study
Authors: Li, S.Y
Yao, W.Y
Yuan, Y.J
Tay, W.S
Han, N.-L.R
Sultana, R
Assam, P.N
Sia, A.T.-H 
Sng, B.L 
Keywords: adult
cesarean section
cohort analysis
controlled clinical trial
controlled study
general anesthesia
lung complication
lung ventilation
major clinical study
patient satisfaction
pregnancy outcome
prospective study
sore throat
cesarean section
clinical trial
general anesthesia
laryngeal mask
respiration control
Airway Management
Anesthesia, General
Cesarean Section
Cohort Studies
Laryngeal Masks
Prospective Studies
Issue Date: 2017
Citation: Li, S.Y, Yao, W.Y, Yuan, Y.J, Tay, W.S, Han, N.-L.R, Sultana, R, Assam, P.N, Sia, A.T.-H, Sng, B.L (2017). Supreme™ laryngeal mask airway use in general Anesthesia for category 2 and 3 Cesarean delivery: A prospective cohort study. BMC Anesthesiology 17 (1) : 169. ScholarBank@NUS Repository.
Abstract: Background: The Supreme™ laryngeal mask airway (SLMA) is a single-use LMA with double lumen design that allows separation of the respiratory and the alimentary tract, hence potentially reducing the gastric volume and risk of aspiration. The purpose of this prospective cohort study is to evaluate the the role of the SLMA as an airway technique for women undergoing category 2 and 3 Cesarean delivery under general anesthesia. Methods: We recruited 584 parturients who underwent category 2 or 3 Cesarean delivery under general anesthesia, in which 193 parturients underwent category 2 and 391 parturients underwent category 3 Cesarean delivery. The primary outcome was insertion success rate at 1st attempt in SLMA insertion. The secondary outcomes included anaesthetic, obstetric outcomes and maternal side effects associated with airway device. Results: The 1st attempt insertion success rate was 98.3%, while the overall insertion success rate was 100%. The mean (Standard deviation) time to effective ventilation was 15.6 (4.4) seconds. Orogastric tube insertion was successful at the 1st attempt in all parturients. There was no clinical evidence of aspiration or regurgitation. No episodes of hypoxemia, laryngospasm or bronchospasm were observed intra-operatively. The incidence of complications was low and with good maternal satisfaction reported. Conclusions: The SLMA could be an alternative effective airway in category 2 and 3 parturients emergency Cesarean Delivery under general anesthesia in a carefully-selected obstetric population. Trial registration: Clinical Trials Registration: Registration NCT02026882. Registered on December 31, 2013. © 2017 The Author(s).
Source Title: BMC Anesthesiology
ISSN: 1471-2253
DOI: 10.1186/s12871-017-0460-x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s12871-017-0460-x.pdf398.36 kBAdobe PDF




checked on Nov 20, 2022

Page view(s)

checked on Nov 24, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.